Product
Patsnap Eureka
For R&D, Patsnap Eureka makes reading and utilizing patents & technical documents easy.
Patsnap Eureka AIR
Designed for self-driven R&D workflows. Generate viable solutions, solve complex R&D challenges, empower your innovation with AI.
Patsnap Eureka Materials
Designed for material experts only. Revolutionize your material R&D, from search, analyze, to developing new materials.
Feature
TechResearch
Generate reliable direction feasibility study reports for your R&D in just a few steps.
TechSeek
Discover and master advanced knowledge NOW. Basics, ideas, possibilities, all at once.
TechMind
As an expert in R&D Theories, TechMind can generates customized viable solutions instantly.
TechRisk
Analyze your overall solution with one click, know your potential R&D risks in advance.
TechMonitor
Get weekly tech updates, stay abreast of the latest tech innovations and key insights.
Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
53 results about "Alternative medicine" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
Alternative medicine describes any practice that aims to achieve the healing effects of medicine, but which lacks biological plausibility and is untested or untestable. In some cases AM treatments are proven ineffective. Complementary medicine (CM), complementary and alternative medicine (CAM), integrated medicine or integrative medicine (IM), and holistic medicine are among many rebrandings of the same phenomenon. Alternative therapies share in common that they reside outside medical science, and rely on pseudoscience. Alternative medicine is distinct from experimental medicine, which employs the scientific method to test plausible therapies by way of responsible and ethical clinical trials, producing evidence of either effect or of no effect. Research into alternative therapies often fails to follow proper research protocol and denies calculalaton of prior probability, providing invalid results. Traditional practices become "alternative" when used outside their original settings without proper scientific explanation and evidence. Frequently used derogatory terms for the alternative are new-age or pseudo, with little distinction from quackery.
Pulsed Magnetic Therapy Device
InactiveUS20110263925A1Good for healthFunction increaseElectrotherapyMagnetotherapy using coils/electromagnetsDiseaseHigh energy
A device for treating diseases and chronic ailments of the human body by inducing powerful, short duration magnetic pulses in close proximity to a region of the body. The device comprises an electromagnetic coil or inductor energized by an electric circuit and a power source, pulsed between 1 and 25 pulses per second for therapeutic means and use as an alternative medical treatment. The device comprises an electric circuit that transmits pulsating current to an induction coil placed within a handheld stylus device for introducing a high energy, pulsed magnetic field to target locations on the body. The stylus is placed against the human body and introduces the pulsating magnetic field into and through body tissue, bone and the bloodstream. The stylus is completely noninvasive and provides a means to direct magnetic energy to a specific part of the body. The device is an advancement in the art, and one that provides increased magnetic energy and pulse frequency without the use of Xenon flash tubes that consume large quantities of power.
Owner:BRATTON CHARLES
Lactobacillus plantarum ZJ316, procreant antibiotic peptides, preparation and use thereof
ActiveCN101353633ABroad-spectrum antibacterialHigh potential for application developmentBacteriaMicroorganism based processesFecesAntibiotic Y
The invention provides a lactobacillus plantarum ZJ316 which is separated from excrement of infants and anti-bacterial peptide which is produced by the fermentation of the lactobacillus plantarum ZJ316, namely plantaricin ZJ316, and preparation and application thereof; the plantaricin ZJ316 is a novel lactobacillus anti-bacterial peptide with high efficiency and small molecular; the anti-bacterial peptide has bacteriostatic action of broad spectrum; due to small molecular weight, a lipid bilayer is hard to be crossed so as to form a complex body with small holes to be different from the action mode of nisin; but the anti-bacterial peptide also has sterilizing capacity with high efficiency, is a lantibiotic anti-bacterial peptide with superhigh application and development potential and can be applied to preparing the alternative medicine of feed additives, food preservatives and antibiotic, etc.
Owner:ZHEJIANG GONGSHANG UNIVERSITY
Probiotics as alternative medicines against infectious diseases
An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
Owner:IMAGILIN TECH LLC
Probiotics as alternative medicines against infectious diseases
An exemplary embodiment providing one or more improvements includes feeding animals with probiotic microbes encapsulated in a mixture of xanthan gum and chitosan, or in gelatin, specifically Pediococcus acidilactici and Saccharomyces boulardii. Such encapsulation protects the viability of the probiotic microbes against unfavorable temperatures. An exemplary embodiment providing one or more improvements includes methods of using viable probiotics in therapy of birds and mammals infected with infectious diseases. Probiotics acted as adjuvants in stimulating antibody reaction and stimulated a cellular immunity response. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
Owner:IMAGILIN TECH LLC
Probiotics as alternative medicines against infectious diseases
A novel representational system that is a method for improving feeding probiotics is provided. The probiotics, especially the Pediococcus acidilactici and the Saccharomyces boulardii are mixed in different colloid net including xanthan, chitosan or gelatin. By using said mixed colloid the activity of the probiotics can be protected, and multiple execrable surroundings and disadvantageous temperature for growth can be prevented. The novel representational method also provides many kinds of method for treating infectious disease for birds and mammals by using activated probiotics. Furthermore, the probiotics is usually acted as adjuvants for improving the generation of antibody and the cellularity immunity effect. In particular, probiotics were shown to reduce the number of viable oocytes from fecal samples, stimulate antibody production, and stimulate of proliferation of splenocytes in chickens infected with Elimeria. In addition, probiotics were shown to relieve symptoms of parvovirus infection in dogs.
Owner:MEDICAL TECHNIC CORP
Stent
An elongate device (19), arcuate in cross-section, for placement around a vessel (4), comprises an essentially non-porous outer layer and a biodegradable inner layer. An alternative device comprises a tubular portion (3) for placement around a graft and a portion (2), arcuate in cross-section that can straddle a native vessel, at the site of an end-to-side anastomosis.
Owner:ARK THERAPEUTICS
Clinafloxacin amino derivatives and application thereof
InactiveCN102030737AHigh antibacterial activityLow toxicityAntibacterial agentsOrganic active ingredientsSolubilityAntibacterial activity
The invention belongs to the field of chemistry and pharmacy, and particularly relates to clinafloxacin amino derivatives and application thereof. The clinafloxacin amino derivatives are the compounds shown in the formula 1 (R is -SO2R1 or -COR2) or pharmaceutically acceptable salts thereof. The antibacterial activity of the derivatives is close to or superior to that of clinafloxacin, the toxicity of the derivatives is lower than that of clinafloxacin, and the solubility and the stability of the solution of the derivatives are superior to those of clinafloxacin. The derivatives can be used for preparing antibacterial medicines, thereby providing more efficient and safe alternative medicines for clinical treatment of infectious diseases and satisfying the demands for clinical treatment in many aspects.
Owner:CHONGQING BASHIDI ANIMAL PHARMA
In-situ gel preparation of potassium dehydroandrographolide succinate and preparation method thereof
ActiveCN101926755AStable in natureQuality is easy to controlOrganic active ingredientsAntipyreticButanedioic acidSide effect
The invention relates to an in-situ gel preparation of potassium dehydroandrographolide succinate and a preparation method thereof. The preparation is prepared from potassium dehydroandrographolide succinate (dehydration andrographolide butanedioic acid ester single sylvite half), in-site gel substrates recognized in the field, and other pharmaceutic adjuvants necessary for other pharmacy by using water as a solvent. In-situ gel of potassium dehydroandrographolide succinate is liquid freely moving outside a body, and forms semisolid gel after patients take the gel. The invention has the advantages of definite effect, stable performance, simple preparation, convenient administration, strong compliance for patients, no toxic and side effect, no untoward effect, high bioavailability, and on the like. The in-situ gel preparation has good antipyretic and antiinflammatory action, can be used for clinically treating viral respiratory tract infection and viral pneumonia, can be used as alternative medicine for potassium dehydroandrographolide succinate injection, and is particularly suitable for infants and patients who have trouble in taking medicine.
Owner:INST OF CHINESE MATERIA MEDICA CHINA ACAD OF CHINESE MEDICAL SCI
System and method of prescribing alternative medications
A system and method is provided to allow a physician to consider alternative medications while he is electronically prescribing medications to the patient, and to also allow the physician to be aware of and provide free medications and / or rebates to the patient.
Owner:SRR PATENT HLDG LLC
Representing visual images by alternative senses
A method of representing visual images by alternative senses is provided herein. The method includes the following stages: obtaining an image of an environment having a background and physical objects distinguishable from the background; slicing the image into a plurality of slices; identifying, for each slice at a time, and slice by slice in a specified order, if at least a portion of the physical objects being contained within the slice; applying, in the specified order, a conversion function to each identified portion of the physical objects for generating a sound or tactile object-dependent signal; associating a sound or tactile location-dependent signal unique for each slice; superpositioning, in the specified order, each object-dependent signal with a respective location-dependent signal for creating a combined object-location signal; and outputting the combined object-location signal to a user via an interface in a form usable for a blind or visually impaired person.
Owner:YISSUM RES DEV CO OF THE HEBREWUNIVERSITY OF JERUSALEM LTD
Application of 9-demethylberberine in preparation of hypolipidemic drug
InactiveCN103919773AFat-lowering effect is goodOrganic active ingredientsMetabolism disorderSide effectMetabolite
The invention provides a hypolipidemic compound 9-demethylberberine. The 9-demethylberberine is derived from a main in-vivo metabolite of natural medicine berberine, and is also named as berberrubine. The researches on model animals with hyperlipidemia find that the 9-demethylberberine has good drug effects of reducing cholesterol, triglyceride, low density lipoprotein (LDL) and the like, and has no obvious side effects for 6 weeks of continuous medication. The discovery can lead to discovery of a new hypolipidemic drug, and provides another alternative medicine for clinic treatment of hyperlipidemia, lipid metabolism disorder and high fat and obese patients and related people wanting to lose weight.
Owner:CHINA PHARM UNIV
Design flood method based on improved prior probability Bayesian model
ActiveCN109635372AHigh precisionReduce the impact of selection uncertaintyClimate change adaptationDesign optimisation/simulationDesign floodAlgorithm
The invention discloses a design flood method based on an improved prior probability Bayesian model, and the method specifically comprises the steps: selecting a plurality of alternative lines, respectively calculating the comprehensive index value of each alternative line, building a Bayesian model according to the comprehensive index value, and calculating the design value of flood through the Bayesian model. According to the Bayesian model design flood method based on the improved priori probability, the precision of the Bayesian model is improved by improving the priori probability, and then the purpose of reducing the linear selection uncertainty influence is achieved, so that the design result precision is improved.
Owner:XIAN UNIV OF TECH
Application of pithecellobium clypearia extracts to preparation of multi-drug resistant acinetobacter baumannii medicine
ActiveCN105816511AReduce dosageAddressing drug resistanceAntibacterial agentsPlant ingredientsAntibiotic sensitivityAntibiotic Y
The invention discloses application of pithecellobium clypearia extracts to preparation of multi-drug resistant acinetobacter baumannii medicine. The pithecellobium clypearia extracts are prepared through the method includes the steps that pithecellobium clypearia coarse powder is extracted with water or an ethyl alcohol solution, the obtained extraction liquid is extracted with ethyl acetate, and the obtained extracts are target products. The antibacterial function of the pithecellobium clypearia extracts to multi-drug resistant acinetobacter baumannii and the sensitivity enhancing function of the pithecellobium clypearia extracts to similar antibiotics are disclosed for the first time. Tests prove that the pithecellobium clypearia extracts and imipenem or tetracycline or polymyxin B or ceftazidime or levofloxacin take effect together, and the use amount of antibiotics can be reduced by 50-87% compared with the mode that only the pithecellobium clypearia extracts are used. The pithecellobium clypearia extracts can serve as natural multi-drug resistant acinetobacter baumannii medicine or an antibiotic sensitivity-enhancing agent, and is applied to treatment of diseases caused by acinetobacter baumannii. A new means and alternative medicine are provided for solving the drug resistance problem of similar antibiotics.
Owner:HUACHENG PHARMA FACTORY GAUNGZHOU
Zebrafish model of thrombocytopenia
The invention provides a zebrafish model of thrombocytopenia. Specially, the invention provides an application of an mplsmu40 mutant zebrafish in preparing an animal model of the thrombocytopenia. With the application of the zebrafish Mpl mutant provided by the invention, studies on human thrombocytopenia as well as large-scale screening of alternative medicines for treating the thrombocytopenia can be implemented.
Owner:SOUTHERN MEDICAL UNIVERSITY
Quinolone imidazole compound as well as preparation method and application thereof
ActiveCN109535176AAvoid drug resistanceEasy to prepare ingredientsAntibacterial agentsOrganic active ingredientsChemical synthesisAntifungal
The invention relates to a quinolone imidazole compound as well as a preparation method and application thereof, and belongs to the technical field of chemical synthesis. The quinolone imidazole compound is shown as general formulas I-IV. The compound has certain inhibition activity on one or several kinds of materials in gram positive bacteria, gram-negative bacteria and fungi, and can be used for preparing anti-bacterial and / or anti-fungal medicine, so that the compound has the opportunity to provide more safe efficient and diversified alternative medicine for clinic antimicrobial treatment;the clinic treatment problems of daily serious drug resistance, stubborn pathogenic microbes, newly occurring harmful microbes and the like can be favorably solved. The preparation raw materials aresimple; the price is low; the obtaining is easy; the synthesis path is short; important significance is realized in aspect of infection resistance. The formulas are shown in the description.
Owner:SOUTHWEST UNIVERSITY
Luminescence assay utilizing a genetically modified cell line
InactiveUS20100009395A1Improve throughputLow levelMicrobiological testing/measurementMaterial analysisAssayChemical compound
An assay method to identify agents that will reduce the inflammation associated with many diseases, providing a method to determine compliance of patients to clinical protocols. The fundamental tool of the inventive method is luminescence. Genetically modified cells are used to express a complex revealing the potential of certain compounds to prevent or reduce adverse effects. More specifically the invention is a method for the determination of inhibition of a chemical compound comprising: culturing genetically modified cells which express an indicator-luminescent complex; placing said complex in the presence of an agent that essentially totally degrades said complex; measuring the luminescence of the resulting reaction; collecting a sample from a mammal consuming a complementary and alternative medicine (CAM); placing said sample in the presence of said complex; and comparing the level of luminescence from step (c) with the luminescence from step (e) to determine the inhibition of said chemical compound.
Owner:RAMANUJAM RAMA P +1
Application of demethyleneberberine in preparation of hypolipidemic drug
InactiveCN103919774AFat-lowering effect is goodOrganic active ingredientsMetabolism disorderSide effectMetabolite
The invention provides a hypolipidemic compound demethyleneberberine. The demethyleneberberine is derived from a main in-vivo metabolite of natural medicine berberine. The researches on model animals with hyperlipidemia find that the demethyleneberberine has good drug effects of reducing cholesterol, triglyceride, low density lipoprotein (LDL) and the like, and has no obvious side effects for 6 weeks of continuous medication. The discovery can lead to discovery of a new hypolipidemic drug, and provides another alternative medicine for clinic treatment of hyperlipidemia, lipid metabolism disorder and high fat and obese patients and related people wanting to lose weight.
Owner:CHINA PHARM UNIV
AI model automatic generation method based on computational graph evolution
ActiveCN109784497AUnicodeAutomate your designGenetic modelsMachine learningLocal optimumEvolutionary computation
The invention provides an AI model automatic generation method based on computational graph evolution. The method mainly comprises the following steps: presetting data; Utilizing a genetic algorithm operator to generate a first-generation calculation graph model and calculating model performance according to a calculation graph structure; removing the invalid model and the repeated model, and reserving the remaining models as alternative models as seeds of the next generation; Selecting a plurality of optimal models; The alternative model generates a calculation graph new model by using a genetic algorithm operator; judging whether the new calculation graph model generated in the last step is generated or not; storing the new model as a new generation of computational graph model, and judging whether the new model meets preset data and evolutionary ending conditions or not; and summarizing evolutionary calculation results, and selecting an optimal model. According to the invention, machine learning and deep learning can be carried out simultaneously. The repeated calculation frequency of the same model is avoided, and the model design efficiency is improved; Jumping out of local optimum; Declining of the performance of the search network is prevented. The evaluation can be directly carried out without training through actual data.
Owner:BEIJING BENYING NETWORK TECH CO LTD
Tetrahydrobenzofuran-4-ketoximetriazole medicine, and preparation method and application thereof
ActiveCN104788436AStrong anti-gastric cancer activityImprove acid suppressionOrganic active ingredientsOrganic chemistryCycloadditionCurative effect
The invention relates to a tetrahydrobenzofuran-4-ketoximetriazole medicine. The medicine is a cis-isomeride of tetrahydrobenzofuran-4-ketoximetriazole medicine, and also comprises pharmaceutically acceptable salts and derivatives of the tetrahydrobenzofuran-4-ketoximetriazole medicine. A preparation method of the tetrahydrobenzofuran-4-ketoximetriazole medicine comprises the following steps: preparing 3,6,6-trimethyl-6,7-dihydrobenzofuran-4(5H)-one (intermediate 1) and nitrine (intermediate 2), carrying out a condensation reaction to convert the intermediate 1 into cis-oxime (intermediate 3), separating, purifying, alkylating to obtain propargyl oxime ether (intermediate 4), and carrying out a copper catalyzed cycloaddition reaction on the intermediate 4 and the nitrine (intermediate 2) to synthesize 1,2,3-triazole substituted furocyclohexanone oxime and a derivative thereof. The above compounds have dual curative effects of antiulcer and stomach cancer resistance, and can be used in stomach cancer treatment as alternative medicines.
Owner:CHINA THREE GORGES UNIV
Personalizing a Meal Kit Service Using Limited Recipe and Ingredient Options
InactiveUS20190243922A1Kernel methodsBuying/selling/leasing transactionsPersonalizationAdditive ingredient
A method, system and computer-usable medium for performing a meal kit personalization operation, comprising: receiving recipe purchase history information for a plurality of customers; associating the recipe purchase history information with a plurality of input recipes; identifying a plurality of input recipes for use for a particular time period; identifying elements of the input recipes that limit appeal of each of the plurality of input recipes for the particular time period, the elements being identified using purchase predictor information relating to the elements; generating alternative recipes based upon the input recipes; and selecting a predefined number of these input recipes and alternative recipes for presentation to a particular user.
Owner:IBM CORP
Medical device's manufacture and usage in alternative medicine for rehabilitation treatment of chronic diseases
InactiveUS20070098814A1Devices for heating/cooling reflex pointsBiocideAlternative treatmentNon invasive
This invention provides information regarding the methods and procedures for manufacturing a new medical device, Health recovery chip kit. It also describes the methods and steps for using this kit to treat the chronic, but non-contagious diseases. The treatment by this kit is safe, more effective, non-invasive and easy to use over other alternative treatments because it does not involve needles, medication, electricity and radiation.
Owner:XU ZHILONG +2
Application of resveratrol and analogs of resveratrol in serving as HIV latent virus reservoir activating agents
The invention discloses application of resveratrol and analogs of resveratrol in serving as HIV latent virus reservoir activating agents.The inventor proves that resveratrol can effectively stimulate rising of expression of GFP protein and a P24 antigen in a cell model through the HIV latent cell model J-lat full length clone 10.6.Thus, resveratrol and derivatives thereof can be independently used or jointly used with other activating medicine for activating the HIV latent virus reservoir in the body of an HIV patient and can serve as an alternative medicine molecule for curing aids.
Owner:SHENZHEN CENT FOR DISEASE CONTROL & PREVENTION
Application of remdesivir in preparation of medicine for inhibiting cardiotoxicity of anti-tumor medicines
ActiveCN112494500AExpanded indicationsHigh application potentialOrganic active ingredientsCardiovascular disorderPharmaceutical drugOncology
The invention discloses application of remdesivir in preparation of a medicine for inhibiting cardiotoxicity of anti-tumor medicines. The invention confirms significant potential of the retegravir asa medicine for inhibiting the cardiotoxicity of anti-tumor medicines, discloses good curative effects of the retegravir on the cardiotoxicity caused by the anti-tumor medicines for the first time, provides an effective novel potential alternative medicine for treating the cardiotoxicity of the anti-tumor medicines, expands indications of the retegravir, and greatly improves application potential and market prospect of the retegravir.
Owner:北京箭牧科技有限公司
Systems and methods for wireless prescription advertising
ActiveUS8694329B1Drug and medicationsAnalogue computers for chemical processesMedication informationSystem maintenance
A medical information system informs prescribers of medically related drug information when preparing a prescription. The point of prescribing messaging system can assist physicians in selecting alternative medications when prescribing medication for patients. The system may include a point of prescription application configured to access and display messages concerning alternative suggested medications of different sponsors in response to an associated selected medication to inform prescribers of the alternative suggested medication for presenting the prescriber with the option of generating an electronic prescription with the alternative suggested medication. A data structure maintained by the system containing associations between a selected trigger medication and a target alternative suggested medication may optionally include additional conditions that control the display of messages such as the gender, age, and / or diagnosis of the patient, the date of the prescription, and / or the region in which the prescription is being made.
Owner:LB FINANCIAL HLDG
ECG signal detection method, device, computer equipment and storage medium
InactiveCN108926341ASave labor costSave material costDiagnostic recording/measuringSensorsEcg signalAlgorithm
The invention provides an ECG signal detection method, a detection device, computer equipment and a storage medium. The detection method comprises the following steps: inputting and training a first ECG signal of a known signal rhythm type in a convolutional neural network so as to obtain corresponding training parameters, and using the convolutional neural network from which the training parameters are obtained as an ECG signal detection model; and inputting and computing a second to-be-detected ECG signal in the ECG signal detection model, and outputting and obtaining a signal rhythm type ofthe second ECG signal. The ECG signal detection model, which undergoes training, can replace medical specialists to complete full automatic detection of signal rhythm types in the ECG signals of a patient, so that a great amount of human and material costs can be saved; and meanwhile, the accuracy of detecting the signal rhythm types in the ECG signals can reach, and even exceed, that of the specialists.
Owner:PING AN TECH (SHENZHEN) CO LTD
Cascading failure search comprehensive assessment method based on probability index and severity index
ActiveCN104112238AReduce the risk of cascading failuresData processing applicationsCascading failurePower grid
The invention provides a cascading failure search comprehensive assessment method based on a probability index and a severity index, by analysis of an operating state of a power grid after each class of failure, a probability index and a severity index of a failure occurring in a next-class alternative line are obtained, and a cascading failure comprehensive risk index of the alternative line is obtained through classified integration. The method is convenient, simple and efficient, and can provide a basis for judging weak links of a system, and making a prevention and control strategy for lowering cascading failure risks.
Owner:ELECTRIC POWER RESEARCH INSTITUTE, CHINA SOUTHERN POWER GRID CO LTD +1
Alternative medicine retrieval apparatus and alternative medicine retrieval method
InactiveUS20190051396A1Improve reliabilitySure easyMedical communicationMedical data miningPharmacyMedication information
Provided are an alternative medicine retrieval apparatus and an alternative medicine retrieval method capable of presenting information regarding an alternative medicine sufficiently suitable for a user's preference and a pharmacy handling the alternative medicine to the user. An alternative medicine retrieval apparatus includes a database (30) that stores medicine information including attribute information of a medicine, a prescription slip data acquisition unit (50) that acquires prescription slip data, a preference information acquisition unit (52) that acquires preference information of a user regarding the attribute information of the medicine, a retrieval unit (54) that retrieves an alternative medicine by referring to the prescription slip data, the medicine information, and the preference information of the user, an information presenting unit that presents, to the user, alternative medicine information and information regarding a pharmacy handling a prescribed medicine and a pharmacy handling the retrieved alternative medicine, and an inspection information acquisition unit (42) that acquires medicine inspection information in the pharmacies, in which the database (30) updates the attribute information according to acquisition of the medicine inspection information.
Owner:FUJIFILM CORP
Lactobacillus plantarum ZJ316, procreant antibiotic peptides, preparation and use thereof
ActiveCN101353633BBroad-spectrum antibacterialHigh potential for application developmentBacteriaAnimal feeding stuffFecesAntibiotic Y
The invention provides a lactobacillus plantarum ZJ316 which is separated from excrement of infants and anti-bacterial peptide which is produced by the fermentation of the lactobacillus plantarum ZJ316, namely plantaricin ZJ316, and preparation and application thereof; the plantaricin ZJ316 is a novel lactobacillus anti-bacterial peptide with high efficiency and small molecular; the anti-bacterial peptide has bacteriostatic action of broad spectrum; due to small molecular weight, a lipid bilayer is hard to be crossed so as to form a complex body with small holes to be different from the action mode of nisin; but the anti-bacterial peptide also has sterilizing capacity with high efficiency, is a lantibiotic anti-bacterial peptide with superhigh application and development potential and can be applied to preparing the alternative medicine of feed additives, food preservatives and antibiotic, etc.
Owner:ZHEJIANG GONGSHANG UNIVERSITY
Wearable vision device
ActiveUS8750969B2Easy to useSimple lightingRaman/scattering spectroscopyPhotometryMouth mucosaMedicine
The present invention aims to provide alternative means for the diagnosis of the risk of developing mouth mucosa cancers by means of fluorescence, easy to use, simple, light and space-saving and diagnostic kits comprising the above-mentioned device.
Owner:PIERREL PHARMA
Method and arrangement for finding a second opinion for disease using modern database, search and matching technology integrated with a social media
InactiveUS20160196403A1Reduce total usageMedical communicationMedical data miningDiseaseSocial media
Techniques for finding a second opinion for a disease using modern database, search and matching technology integrated with a social media making it possible for patients, relatives, family, friends, doctors, nurses, holistic and alternative medicine professionals or other professionals in the health profession to find a second opinion for the disease. The solution is global and may be made available for all patients, professionals in the health profession, family, friends, and others with the same disease or other relatives.
Owner:YOUR MD
Who we serve
- R&D Engineer
- R&D Manager
- IP Professional
Why Patsnap Eureka
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com